Wealth Enhancement Advisory Services, LLC Cyclo Therapeutics, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $37 Billion
- Q1 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Cyclo Therapeutics, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 20,400 shares of CYTH stock, worth $24,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,400
Previous 18,513
10.19%
Holding current value
$24,888
Previous $29,000
3.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CYTH
# of Institutions
22Shares Held
2.16MCall Options Held
0Put Options Held
0-
Epiq Capital Group, LLC San Francisco, CA854KShares$1.04 Million0.47% of portfolio
-
Founders Fund V Management, LLC San Francisco, CA481KShares$586,4633.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA397KShares$483,9220.0% of portfolio
-
Geode Capital Management, LLC Boston, MA160KShares$194,8930.0% of portfolio
-
Founders Fund Vi Management, LLC San Francisco, CA110KShares$134,22857.89% of portfolio
About Cyclo Therapeutics, Inc.
- Ticker CYTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 8,439,440
- Market Cap $10.3M
- Description
- Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of...